COMP <GO>
ASTH vs AMZN // GROSS PROFIT MARGIN
Astrana Health Inc. (NASDAQ) VS. Amazon.com, Inc. (NASDAQ) • 15-METRIC TALLY: ASTH 2
— AMZN 6
■ METRIC PARITY
LAST: $36.62 (-0.14%) • MKT CAP: $1.82B
gross-margins
—
LAST: $243.79 (-4.25%) • MKT CAP: $2.63T
gross-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ASTH VS. AMZN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ASTH | AMZN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.60% | 17.61% | -13.01 | AMZN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 27.3x | 15.8x | +11.55 | AMZN | /valuation <GO> |
| Free Cash Flow Yield | 5.75% | -1.81% | +7.56 | ASTH | /fcf-yield <GO> |
| Operating Margin | 2.50% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 0.80% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 56.40% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.43% | 0.00% | +0.43 | ASTH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.54 | 3.32 | -0.78 | AMZN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 6/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.73% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.7 | 47.2 | -0.48 | AMZN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.46 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 63.6x | 22.8x | +40.85 | AMZN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.82B | $2.63T | -$2.63T | AMZN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ASTH REV | AMZN REV | ASTH GROSS % | AMZN GROSS % | ASTH FCF | AMZN FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $0 | — | — | — | -$46.89B |
| FY 2025 | $3.18B | $0 | — | — | $104.5M | $10.56B |
| FY 2024 | $2.03B | $0 | — | — | $44.2M | $42.95B |
| FY 2023 | $1.39B | $0 | — | — | $68.2M | $16.92B |
| FY 2022 | — | $0 | — | — | — | -$26.32B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ASTH // BETA —
AMZN // BETA 1.46